IRVING, TX–(Marketwire – July 14, 2010) –  VHA Inc., the national health care network, announced the formation of a national Value Based Purchasing (VBP) Advisory Panel. The panel, which consists of nationally-recognized experts, will help hospitals and clinicians transition into this new environment, where reimbursements are linked to quality and safety outcomes. The panel members were selected because they represent a broad array of clinical, operational, and behavioral disciplines with knowledge and experience related to specific components of the government’s value-based purchasing initiative or the environment in which it will operate. Through the efforts of the advisory panel, hospitals and clinicians will gain better insights into the choices and issues that arise with value-based purchasing. 

“The value-based purchasing environment is not simply about looking at performance measures and tracking progress,” said Trent Haywood, MD, JD, chief medical officer at VHA and a former deputy chief medical officer at the Centers of Medicare and Medicaid Services. “Instead, it is a new focus on how we can collectively create more value for patients, clinicians, and providers. For value creation to occur, we need broader insights into the choices we have. The diverse background and expertise of the panel provides these insights.”

Beginning Oct. 1, 2012, through its value-based purchasing program, CMS will link hospital payments to clinical quality and patient experience scores. Hospitals that don’t perform well could lose millions of dollars in Medicare reimbursements. In May 2010, VHA announced the creation of its Value Insurance Program Services, precisely designed to help member organizations focus on specific VBP performance improvement needs. 

“Reimbursement from payers, both government and private insurers, has long been based on the volume of care delivered, but the reimbursement model of the future will be based almost exclusively on the value that’s provided, and hospitals will struggle to adapt to this shift,” said panel member David B. Nash, MD, MBA, dean of the Jefferson School of Population Health. “The panel will provide unbiased insight into the changes that must occur across health care for implementation of value-based purchasing. Without this sort of guidance, the industry may be delayed in developing positive momentum to adopting value-based purchasing.”

The members of the VHA VBP Advisory Panel include:

1. Ann Scott Blouin, RN, PhD, Executive Vice President, The Joint Commission, Oakbrook Terrace, Ill.
2. Dale Bratzler, DO, MPH, President/CEO, Oklahoma Foundation for Medical Quality, Oklahoma City, Okla.
3. Eric A. Coleman, MD, MPH, Director, Care Transitions Program, Denver
4. Helen Darling, President, National Business Group on Health, Washington, D.C.
5. R. Adams Dudley, MD, MBA, Professor of Medicine and Health Policy, Associate Director for Research, Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco
6. Susan Edgman-Levitan, PA, Executive Director, John D. Stoeckle Center for Primary Care Innovation, Massachusetts General Hospital, Boston
7. Nancy Foster, Vice President for Quality and Patient Safety Policy, American Hospital Association, Washington, DC.
8. Judith Hibbard, DrPH, Senior Researcher, Institute for Policy Research and Innovation, Professor, Department of Planning, Public Policy and Management, University of Oregon, Eugene, Ore.
9. David Hunt, MD, FACS, Medical Director, Office of Provider Adoption Support, Office of the National Coordinator for Health IT, Washington, D.C.
10. Ann Jordan, PhD, Professor of Anthropology, University of North Texas, Denton, Texas
11. Beverly Jordan, RN, Vice President of Nursing/Chief Nurse Executive, Baptist Memorial Health Care, Memphis, Tenn.
12. Harlan M. Krumholz, MD, SM Harold H. Hines, Jr. Professor of Medicine and Epidemiology and Public Health, Yale University School of Medicine, New Haven, Conn.
13. Rob Maurer, PhD, Associate Professor, Health Systems Management, Texas Woman’s University, Dallas
14. David B. Nash, MD, MBA, Dean, Jefferson School of Population Health, Philadelphia
15. Greg Pawlson, MD, MPH, Executive Vice President, National Committee for Quality Assurance, Washington, D.C.
16. Michael Rapp, MD, JD, FACEP, Director of Quality Measurement & Health Assessment Group, Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services, Baltimore
17. Victoria Rich, RN, PhD, Chief Nurse Executive, Hospital of the University of Pennsylvania, Philadelphia
18. Meredith Rosenthal, PhD, Associate Professor, Health Economics and Policy, Harvard School of Public Health, Boston
19. Thinh H. Tran, MD, Chief Medical and Quality Officer, Baptist Health South Florida, Miami
20. John Vassall II, MD, FACP, Chief Medical Officer, Swedish Medical Center, Seattle
21. Stephen Wallenhaupt, MD, Executive Vice President/Chief Medical Officer, Novant Health, Winston-Salem, N.C.

ABOUT VHA
VHA Inc., based in Irving, Texas, is a national network of not-for-profit health care organizations that work together to drive maximum savings in the supply chain arena, set new levels of clinical performance and identify and implement best practices to improve operational efficiency and clinical outcomes. Formed in 1977, through its 16 regional offices, VHA serves more than 1,400 hospitals and more than 25,500+ non-acute care providers nationwide. VHA was ranked by Modern Healthcare as the 7th best place to work in health care in 2009.

CLEVELAND, OH–(Marketwire – July 14, 2010) –  Relational Solutions announces the release of their new BlueSky Excel Builder. Life just got easier for Excel users with the BlueSky Excel Builder. BlueSky Excel Builder lets you create powerful spreadsheets from database queries quickly and easily. Users can mix and match data from multiple data sources using the dataset Wizard. This allows users to create queries without having to know anything about databases or the SQL language.

Pivot Tables made easy: BlueSky Excel Builder automatically pulls in the data and creates the Pivot Tables for you! Once data is in Excel, you simply use all the built in Excel features. Thus, there is no learning curve!

Distribute Excel Workbooks with security and data transparency: You can share Excel reports and report templates with other users simply by emailing it to them. If the user has the Excel Builder plug-in, they can update the report with a single mouse click and it will repopulate it with data relevant to their business area. Thus, Excel reports are updated with built-in security so that users get only what they are allowed to see providing total transparency to the business user.

Create Standardized Excel presentations: BlueSky Excel Builder is great for creating standardized Excel templates for Account Teams and casual users. Account Team members only need to click the “Refresh Data” button and the report will contain only the data they are entitled to see. It doesn’t get any easier!

Do you have PowerPoint Presentations linked to your Excel reports? Reports and charts linked from Excel to PowerPoint are also, repopulated when you click the “Refresh” button.

Integrated with Wal-mart RetailLink: User who want to directly populate their Excel reports with data they download from Walmart’s RetailLink, can now update their pre-designed Excel reports without the need to recreate their reports each time. This is because we have built our RetailLinker application right into our BlueSky Excel Builder. Wal-mart analysts can now easily update Wal-mart reports in Excel. Our Wal-mart Compliance Report and Request for Routing report can also be updated in three easy steps.

About Relational Solutions, Inc.
Based in Westlake, Ohio since 1996, RSI is a software and service company specializing in data integration and demand signal repositories for consumer goods companies. POSmart expedites the integration, cleansing and harmonization of point of sale data with syndicated, third-party and internal data, to improve retailer relationships, support customers better, streamline internal efficiencies, decrease OOS’s, and maximize profits. Applications include POSmart, POS Data Manager, BlueSky Analytics, BlueSky Forecaster, Promotion & New Item Tracking, RetailLinker, BlueSky ExcelBuilder and BlueSky Integration Studio (BIS).

Click here to see all recent news from this company

TORRANCE, CA–(Marketwire – July 14, 2010) –  Dr. Ramin Mirhashemi, MD, FACOG, of Gynecological Oncology Associates realized he needed to have an online presence and branding for his practice. With the help of Aurora Information Technology, his website GYNLA.com is the ultimate medical resource for his patients. Dr. Mirhashemi is an expert in robotic surgery, which he performs to treat gynecologic cancers including uterine, ovarian, cervical, and vaginal cancers, as well as fibroids, endometriosis, ovarian tumors and pelvic prolapse (robotic sacrocolpopexy, robotic hysterectomy and robotic myomectomy).

The domain name, GYNLA.com, was devised to encompass the practice and the region served. A fun and bright website design with an animated banner incorporating the fresh, new logo on the home page houses a wealth of information on topics in Dr. Mirhashemi’s overall gynecological expertise, including gynecologic oncology and robotic surgery. Mirhashemi developed techniques to perform these surgeries through robotic laparoscopic techniques. The robotic procedure is more accurate and minimally invasive, due to smaller incisions. Patients experience less pain and usually recover in about 1 week.

Dr. Mirhashemi, who has the largest experience in robotic surgery for gynecologic conditions “west of the Mississippi,” is a subject matter expert who has published over 60 journal articles, research articles and book chapters in regards to women’s health. Mirhashemi attended Medical School at the University of Southern California and completed his internship and residency at the Brigham and Women’s Hospital/Massachusetts General Hospital at Harvard Medical School. He received his fellowship in Gynecologic Oncology at the University of Miami. To his credit, he is a former Associate Professor of Obstetrics and Gynecology at the UCLA School of Medicine, and the University of Miami School of Medicine, as well as the Director of the Familial Breast and Ovarian Cancer Genetic Center at the University of Miami School of Medicine.

Because Dr. Mirhashemi is dedicated to improving women’s health via comprehensive gynecology, gynecologic oncology, and urogynecologic services, his mission for the website was to provide as much information as possible regarding the most common female medical conditions as well as treatment options. Mirhashemi believes in the efficiency of state-of-the-art robotic surgery in gynecology. “Because large abdominal incisions are not needed with the da Vinci robot that is used in robotic surgery, my patients recover much faster than with traditional open surgery, that requires these larger incisions,” explained Mirhashemi. “With robotic surgery, most of patients are discharged within 24 hours of their operations, with fewer complications.”

The site provides patient information such as physician/practice background, patient testimonials and hospital affiliations. In order to constantly improve the patient experience, the site features an online patient questionnaire that captures patient feedback on their experience with the practice. “My practice is patient-focused and their cure and satisfaction go hand-in-hand,” explained Dr. Mirhashemi. “If we’ve managed to do both successfully, and provide the value-add of medical information and education, then we’ve done our job well.”

Click here to see all recent news from this company

WAYNE, PA–(Marketwire – July 14, 2010) – Clinical and Laboratory Standards Institute (CLSI) recently published “Validation, Verification, and Quality Assurance of Automated Hematology Analyzers; Approved Standard–Second Edition” (H26-A2). This document covers portions of the life cycle of an automated multichannel hematology system and provides guidance for manufacturers’ validation, end-user laboratory verification, calibration, quality assurance (QA), and quality control (QC) through standardized approaches to ensure good science and clinical relevance.

Albert Rabinovitch, MD, PhD, NovoMetrics, Inc., and chairholder of the subcommittee that developed the document, says, “This new document applies the most current scientific and medically relevant approaches to assessment of automated hematology systems, replacing the shortfalls created by disparate individual sources. Beyond scientific presentation of theory, H26-A2 provides very detailed practical information (including appendices) on method evaluation that all readers will find useful. It serves as a model for clinical laboratory test systems in general, not just hematology.”

Historically, each complete blood count (CBC) instrument/reagent manufacturer developed its unique approaches to system validation and performance claims. This standard will help create better standardization among manufacturers, as well as assist practicing laboratories in developing consistent testing.

The intended audience includes manufacturers of such devices, end-user clinical laboratories, accrediting organizations, and regulatory bodies. End-user clinical laboratories will also find guidance for establishment of clinically reportable intervals (CRIs) and for QA for preexamination and examination aspects of their systems.

CLSI is a volunteer-driven, membership-supported, nonprofit organization dedicated to developing standards and guidelines for the health care and medical testing community through a consensus process that balances the perspectives of industry, government, and the health care professions. For additional information on CLSI, visit the CLSI website at www.clsi.org or call 610.688.0100.

Click here to see all recent news from this company

DENVER, CO–(Marketwire – July 14, 2010) –  Eating Recovery Center, a national eating disorders recovery program providing comprehensive treatment for anorexia and bulimia, today announced the opening of a new outpatient location. Enabling Eating Recovery Center to expand its outpatient recovery services, the new Denver, Colo. office will offer integrated care for eating disorders in a flexible outpatient setting. 

“This expansion allows Eating Recovery Center to offer patients a collaborative, team-based approach to outpatient eating disorder treatment,” said Kenneth L. Weiner, MD, CEDS, co-founder and medical director of Eating Recovery Center. “With access to a team of individual and family therapists, dietitians, and medical professionals, patients benefit from a well-rounded treatment experience that can help them achieve sustainable recovery.”

The outpatient clinical team works together to help individuals and families who are new to eating disorder treatment address disordered eating and body image issues before they have the chance to escalate. The clinicians are also committed to helping individuals who have been in a recovery program stay on track as they move into lower levels of care. The services offered include individual and family therapy, dietary counseling, psychiatric medical management, body image and aftercare eating disorder support groups, and an evening intensive outpatient program, which begins this month. 

The evening intensive outpatient program is an integrated option for individuals who require more structure than individual counseling provides. Participants meet Mondays, Wednesdays and Thursdays from 5 to 9 p.m. and take part in individual counseling, group therapy, nutrition education and multifamily therapy. They learn to break patterns that maintain their diseases and integrate sustainable changes into their lives. The timing of the program enables participants to integrate the skills learned in evening sessions into their daily lives.

“Eating disorders are complex conditions and every person’s experience with the disease is different,” explains Weiner. “The evening intensive outpatient program allows us to tailor treatment to the individual needs of each patient and promote successful recovery.” 

Eating Recovery Center also operates a licensed behavioral hospital for adults with severe eating disorders, and will open an adolescent treatment facility in the Denver Lowry neighborhood in October 2010. All services are guided by the leadership and clinical expertise of Weiner and Emmett R. Bishop, Jr., MD, CEDS, co-founders of Eating Recovery Center and nationally renowned experts who have separately founded numerous other eating disorder programs throughout the country.

The outpatient office is now open at 600 S. Cherry Street, Suite 600, in Denver, Colo. For more information or to make an appointment, please call 877-218-1344. 

About Eating Recovery Center
Eating Recovery Center is a national eating disorders recovery program, providing comprehensive treatment for anorexia and bulimia at the foot of the Rockies in beautiful downtown Denver, Colorado. Facilities include a licensed behavioral hospital treating adults, an outpatient office, and an adolescent facility scheduled to open in October 2010. Our integrated program offers patients from across the country a continuum of care that includes inpatient, residential, partial hospitalization, intensive outpatient and outpatient services. Our compassionate team of professionals collaborates with treating professionals and loved ones to cultivate lasting behavioral change. For more information please contact us at 877-218-1344 or [email protected] or confidentially chat live on our website.

Click here to see all recent news from this company

MIAMI, FL–(Marketwire – July 14, 2010) – Unity Management Group Inc. (PINKSHEETS: UYMG) is a Health Resource Company specializing in Physician and Hospital Practice Management, Medical Discount Plans, Business Services, Billing Software and Technologies.

UMGI is proud to announce that is has entered into a negotiation for an acquisition that will increase its revenue and assets.

Unity is in a due diligence stage of acquiring a healthcare related company. In the coming week we will be updating share holders with financials and corporate information of the target company.

UMGI management feel s that this can be a perfect fit and the company is fully funded.

The funding requirements for the acquisition have been obtained. Further information will be released in the next 7 business days.

Unity Management Group Inc. is also proud to announce that it has completed its disclosure statement, and legal opinion in respect that these are the listing documents that are necessary to obtain current status on the OTC markets. We foresee us receiving our PS status by Friday.

“We are proud to announce these extremely important current events. As previously mentioned this is a milestone for UMGI, and the company is working diligently to complete this acquisition, we will be announcing the outcome of these events within the next couple of business days. As always the company would like to thank its past present and future investors,” said Michael Oliver, Vice President.

For more information please goes to our website which can be found at www.unitymanagementgroup.com

Share structure:

100,000,000 million authorized

87,035,620 million issued and outstanding

43,439,460 million float

Unity Management Group, a health resource company, will continue to provide innovative physician practice management services that offer high value and significant return on investment for physicians’ practices and hospitals through its three subsidiary companies: United Healthcare Solutions Inc., Unity Technologies Inc., and United Business Services Inc.

The first subsidiary, Unity Business Services, is a full service management company offering solutions in practice management, billing, staffing, contracting, licensing, credentialing, and accounting. Unity Business Services also offers assistance in HIPPA compliance, marketing, and unique solutions for practice start-ups and new practices.

Unity Technologies Inc. is a complete software solutions company offering billing, electronic medical records, and electronic health records for physician’s offices and hospitals.

United Healthcare Solutions, a national company based in Nevada, is a healthcare company that will be providing medical, vision and dental discount plans, as well as PPO and HMO networks. 

The combination of these three subsidies provides unprecedented access to skilled leadership, managed care expertise, information systems, and economies of scale. Alex Berkovich, President of United Management Group, stated, “Through this merger, we are in a unique position to address the rapidly changing needs of the medical community. Business expertise is critical to the success of today’s physician offices and hospitals and we expect unpatrolled growth in the near future.”  

Certain information discussed in this press release may constitute forward-looking statements within the Private Securities Litigation Reform Act of 1995 and the federal securities laws. Although the Company believes that the expectations reflected in such forward-looking statements are based upon reasonable assumptions at the time made, it can give no assurance that its expectations will be achieved. Readers are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements are inherently subject to unpredictable and unanticipated risks, trends and uncertainties such as the Company’s inability to accurately forecast its operating results; the Company’s potential inability to achieve profitability or generate positive cash flow; the availability of financing; and other risks associated with the Company’s business. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events.

TUSTIN, CA–(Marketwire – July 14, 2010) –  Radient Pharmaceuticals Corporation (NYSE Amex: RPC), a US-based pharmaceutical company, has announced the launch of its newly designed website located at www.radient-pharma.com and new corporate video featured on RPC’s new corporate website and recently launched Onko-Sure™ product website located at www.onkosure.com.

RPC’s new corporate website offers visitors ease of use and informative, comprehensive in-depth information on RPC’s company, management, products, and strategic plans. This site also provides a more comprehensive and informative investor relations section that will be of great interest to existing shareholders, prospective investors, the investment community in general, and the Company’s customers and strategic partners. Additionally, site visitors can now access more in-depth information on RPC’s corporate and product commercialization strategy, timeline and progress through RPC’s new corporate video which is accessible via www.radient-pharma.com and www.onkosure.com.

According to Douglas MacLellan, Chairman and CEO of Radient Pharmaceuticals, “Radient Pharmaceuticals is committed to providing and maintaining strong communication with our existing shareholders and prospective investors; the medical and healthcare community at large; and partners, suppliers, and customers. It is our expectation that with this new , informative and highly user-friendly design, RPC’s refreshed website will provide a more effective platform for the dissemination of news, updates, webcasts and pertinent shareholder and investor relations information concerning the company. As our company grows, we will continue to update our website with features and content that help our key audiences learn about what we do and the value we provide through our strong portfolio of cancer products, vaccines and therapies.”

Highlights of the newly designed RPC website include the following:

• Functional and Highly Intuitive Interface: RPC’s website was designed to provide ease of use, featuring a multi-level navigation that allows users to quickly access desired content.
• In-depth Investor Relations Section: includes investor highlights, RPC’s company history, and operations overview. In addition, this section offers RPC’s quote and data SEC filings, news releases, webcasts, analyst reports and information on the company’s strategic plans.
• Management: a listing of the company’s Directors and Executive Officers along with their respective bios and e-mail contacts.
• Product Portfolio and Associated Materials: A detailed overview of RPC’s product portfolio that includes clinical data and resources, regulatory and patent information, research and development initiatives, product innovations and relevant product news as it relates to our strategic plans and industry developments.
• Corporate Video: new video that provides in-depth details on RPC’s corporate and product commercialization strategy, timeline and progress.

Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is a US-based pharmaceutical company specializing in the research, development and sales of In Vitro Diagnostic Cancer tests. The Company’s focus is on the discovery, development & commercialization of unique high?value diagnostic tests that help physicians answer important clinical questions related to early disease detection; treatment strategy; and the monitoring of disease progression, prognosis, and diagnosis to ultimately improve outcomes for patients. Our Onko?Sure™ IVD cancer test is used to guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, perform additional testing, or assist in the selection of therapy. For additional information on RPC and its portfolio of cancer products visit the Company’s corporate website at www.Radient-Pharma.com. For Investor Relations information contact Kristine Szarkowitz at [email protected] or 1.206.310.5323.

About Radient Pharma:
Headquartered in Tustin, California, Radient Pharmaceuticals Corporation is an integrated pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, and premium skin care products.

Forward Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company’s operations, markets, services, products, and prices. With respect to Radient Pharmaceuticals Corporation, except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

Click here to see all recent news from this company

SKOKIE, IL–(Marketwire – July 14, 2010) –  According to Sg2, a future-focused health care information company, a hospital would need to reduce its direct costs by an average of $1,082 per case, or 14%, to sustain its current operating margins if average inpatient payments were paid at today’s Medicare rates. This finding comes on the heels of recent economic trends that indicate commercial payers may begin decreasing their reimbursement rates in the near term.

Sg2’s analysis suggests that providers must assume more accountability across the care continuum by improving clinical performance and significantly reducing costs to better manage to Medicare margins. With MedPAC projections of overall Medicare margins to be -5.9% in 2010 and performance-based penalties looming, the threat of commercial insurance reimbursement rates approaching Medicare levels in some markets adds tremendous financial pressure to health providers.

The number of Medicare patients will nearly double between 2005 and 2030 as the 78 million members of the Baby Boomer generation begin turning 65 in 2011. Additionally, tough economic conditions continue to make it increasingly difficult for employers to afford health insurance coverage, thereby placing more pressure on commercial payers to reduce premium costs. This, in turn, forces payers to reduce reimbursement rates to providers — rates that could eventually approach Medicare levels in some regions.

According to the Centers for Medicare & Medicaid Services (CMS), 40% of total Medicare spending is “waste” caused by issues including provider error, unnecessary care, avoidable admissions and lack of care coordination. This new playing field sets the stage for health providers to dramatically cut costs and improve clinical performance to meet market dynamics. One strategy that providers can implement is a disease-centered clinical approach that will help organizations identify the top Medicare severity diagnosis-related groups (MS-DRGs) with the highest cost reduction opportunities. Another effective measure is for hospitals to improve their level of clinical integration by assessing their performance across all inpatient and outpatient settings. This is effectively addressed through Sg2’s Systems of CARE™ (Clinical Alignment and Resource Effectiveness) methodology, which measures and monitors key health reform performance metrics such as potentially avoidable admissions and 30-day readmissions.

“This changing environment requires a radical shift in behavior. The onus firmly resides with the provider,” says Sg2 Chairman and CEO Michael Sachs. “The health care leader of the future must recognize incremental and long-term cost saving strategies today, while still delivering cost-effective, quality care. In order to survive and thrive, it is imperative for all organizations — regardless of size — to create a clinically integrated framework and understand financial implications of the growing Medicare population and performance-based incentives. Now is the time to implement a disease-centered approach that not only uncovers financial opportunities, but addresses clinical performance across both inpatient and outpatient settings.”

Sg2’s analysis is grounded in its Sg2 INSIGHT™ Clinical Performance Management System comparative database and the National Inpatient Sample (NIS). A hospital’s potential cost reduction exposure varies by market, provider type and size, with large community hospitals requiring the greatest percentage cost reduction at 17% to maintain overall operating margins at today’s Medicare reimbursement rates. For small- to medium-sized community hospitals, the average cost reduction is $849 per case and for academic medical centers it is $1,168 per case. Case mix, payer mix and relative payment levels drive the differences. For more information on this analysis, contact Sg2.

About Sg2
Sg2 is a health care information company that provides expert-led, future-focused systems for growth and clinical performance. Our advanced analytics, business intelligence, education and publications deliver measurable value across the full continuum of health care services. Sg2 works with more than 1,000 hospitals and health care organizations in the US and around the globe. For more information, visit www.sg2.com.

HOUSTON, TX–(Marketwire – July 14, 2010) –  Bederra Corporation (PINKSHEETS: BEDA) management has announced that it has submitted all necessary information to obtain Pink Sheets Current Information status and should obtain this status on otcmarkets.com within the next few days. This increased level of disclosure is intended to enhance shareholder transparency.

According to otcmarkets.com, “Companies that follow the International Reporting Standard or the Alternative Reporting Standard by making filings publicly available through the OTC Disclosure & News Service pursuant to Pink OTC Markets Guidelines for Providing Adequate Current Information are designated as Pink Sheets Current Information.” In its May 2010 OTC Market Snapshot, OTC Markets revealed that of 9,402 OTC companies, 1,237 were Pink Sheets Current Issuers. In May, trading in Pink Sheets Current Issuers accounted for more than 53% of the total trading dollar volume of OTC companies.

The company also announced that it has changed its Transfer Agent and has employed Transfer Online to streamline its securities management.

Management continues to seek additional acquisitions and diversification in an effort to bring long-term value to shareholders.

In the coming weeks the company will announce several actions that management believes will increase the long-term success of the company.

About Bederra Corp.
http://www.bederra.com
Bederra Corporation provides multiple modality diagnostic medical services to the greater Houston area and the world famous Texas Medical Center. The Company’s business strategy is to continue to expand its current operations and seek out additional acquisitions that will complement its core offerings.

Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company’s expectations with regard to the future impact on the company’s results from new products and services in development, including any planned acquisitions, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The results anticipated by any or all of these forward-looking statements might not occur. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events or changes in the Company’s plans or expectations.

WICHITA, KS–(Marketwire – July 14, 2010) – Pulse Systems, Inc., an industry-leading vendor of ambulatory healthcare software solutions, announced that today’s finalization of stage one Meaningful Use measures will remove uncertainty from the market and unleash widespread adoption of effective electronic health record technology — such as Pulse EHR — while displacing substandard systems. “With more than 300 solutions currently calling themselves EHRs, we anticipate these rules will quickly whittle that list down to a few critical players,” said Senior Vice President Bruce Rowley.

Though the finalized measures were released today, the Pulse solution has been allowing users to meet Meaningful Use for months. The Pulse Patient Relationship Management version 4.1.02 was the first solution to become a fully CCHIT Certified® 2011 Ambulatory EHR, proving it allowed users to meet the previously proposed Meaningful Use measures. “From the very beginning, our development strategy has been aligned with the HHS vision, while most of our competitors seem to have been hoping for watered-down measures that would allow their systems to qualify,” said Senior Vice President of Healthcare Information Systems Chris Gregg. 

Gregg continued, “Pulse is unique in the marketplace as a company that built every aspect of its solutions by drawing from a single patient record and database, creating one of the only end-to-end, organic systems in existence,” he said. “Most of the ‘solutions’ offered by larger companies have been stitched together through acquisitions of separate systems over the last decade leading to fragile internal interfaces and limited cross-module access to data.”

Gregg also acknowledged that fulfilling stage one Meaningful Use requirements is not enough to ensure the future of an EHR. “Interoperability is paramount to future relevancy in the medical industry,” he said. “We support the open transaction of information, and we have demonstrated this through our use of standardized language and codified data. This helps us to be prepared for the measures we expect to see in stages two and three of Meaningful Use.”

CEO and President of Pulse Basil Hourani reiterated, “Pulse has been ready for these measures to become finalized so our clients can receive the maximum allowable ARRA stimulus payments. Pulse provides an easier way to meet the Meaningful Use guidelines and we are proud to be among the few solutions truly prepared to lead the healthcare industry into the next chapter in EHR technology.”

About Pulse Systems, Inc.
Pulse offers Electronic Health Records (EHR), Practice Management, ePrescribing and Revenue Cycle Management (Billing Services) used nationwide in more than 26 medical specialties. Pulse Practice Management and EHR products have both earned five star ratings from AC Group. Since 1982 Pulse has focused on its mission to develop, market and support healthcare practice workflow solutions that are easier to purchase, implement, utilize and upgrade. This focus on making things easier for clients is the key to a remarkable 95% client renewal rate. For more information, visit www.pulseinc.com.

Click here to see all recent news from this company

SAN FERNANDO, CA–(Marketwire – July 14, 2010) – Precision Dynamics Corporation, the global leader in healthcare identification solutions, announced today the release of the new Securline^® Bar Code Blood Band, a blood recipient ID wristband system that provides automated patient identification for blood transfusion, specimen collection, and tracking. As the only snap closure bar code blood band on the market, the product allows caregivers and phlebotomists to apply the band to patients quickly, correctly, and securely.

The Securline^® Bar Code Blood Band uses serialized bar code ID and alpha-numeric codes to accurately match the right patient to the right blood. This improves patient safety by reducing identification related human errors that can occur during the blood transfusion process. The product’s 12 matching bar code labels (four on the wristband and eight on the detachable tail that is applied to blood tubes) can be applied to additional draw tubes, patient chart, transfusion requisition, and as a secondary label on blood bags. A clear, adhesive shield on the wristband’s information area protects the patient ID labels and bar code from moisture or solvents for accurate bar code scanning. Soft, latex-free material maximizes patient comfort and safety yet is also durable and strong.

In contrast to the other leading bar coded blood wristband on the market, the Securline^® Bar Code Blood Band features an easy-to-use snap style closure and secure bar code labels, saving hospital staff valuable time and unnecessary frustration. Mary Ann Sharpe, Blood Bank Manager at Research Medical Center which belongs to HCA Midwest Health System, stated, “Securline^® Bar Code Blood Bands are easy to apply because the bands snap closed just like our admission wristbands. The other bar code blood bands we were using before were complicated and our staff struggled with putting the bands on patients. Plus, the bar code labels on the Securline^® product are very secure and don’t peel off accidentally like we experienced with the other band.”

“Bar coding continues to bring improvements in patient safety as hospitals adapt the technology to reduce human errors,” said Kim Canchola, Product Manager for Precision Dynamics. “The added bonus is the increase in productivity as hospitals use sheeted labels with bar codes instead of writing patient ID info by hand. The Securline^® Bar Code Blood Band combines the sophistication and functionality of bar coding for blood transfusions with the simplicity and comfort of a high quality, non-transferable identification wristband. The positive response we’ve received from our customers about their experience with this product is rewarding because we know we’re helping solve their problems by doing what we do best — delivering first-class identification solutions.”

The Securline^® Bar Code Blood Band meets current Joint Commission, AHA, and HIPAA requirements. For more information, please visit: www.pdcorp.com/healthcare or contact PDC’s Customer Care at 800-772-1122.

About Precision Dynamics Corporation:
The Leading Provider of Positive ID and Positive Outcomes™
With more than 50 years of experience, Precision Dynamics provides accurate, reliable, and easy-to-use healthcare ID solutions that empower the flawless delivery of care and enhance outcomes across all major hospital functions. Our products are used in all of the leading hospitals worldwide and comprise a comprehensive range of wristband and labeling systems that provide positive ID and positive clinical outcomes.

Precision Dynamics products meet important guidelines of The Joint Commission, World Healthcare Organization, FDA, AHA, and HIPAA. As the developer of the first single-piece patient wristband, the first bar code wristband system, and the first Smart Band® RFID wristband system, Precision Dynamics solutions are an integral part of some of the most successful patient safety initiatives. As an ISO 9001 certified company, Precision Dynamics follows a systematic, world-standard approach to ensure superior product design, manufacturing, and customer support services.

DUBLIN, IRELAND–(Marketwire – July 14, 2010) –   Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter of 2010 on Thursday, July 29, 2010. The Company has scheduled a conference call for that same day, Thursday, July 29, 2010 at 11:00am EDT (4:00pm BST) to discuss the results of the quarter.

Interested parties can access the call by dialing:

A simultaneous webcast of the call can be accessed at: http://www.videonewswire.com/event.asp?id=70724

A replay of the call can be accessed until August 3, 2010 by dialing:

The webcast of the call will be available for 30 days at: http://www.videonewswire.com/event.asp?id=70724

About Trinity Biotech plc
Trinity Biotech develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market. The products are used to detect infectious diseases and blood coagulation disorders, and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. Trinity Biotech sells direct in the United States, Germany, France and the U.K. and through a network of international distributors and strategic partners in over 75 countries worldwide. For further information please see the company’s website: http://www.trinitybiotech.com. 

Forward-looking statements in this release are made pursuant to the “safe harbor” provision of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties including, but not limited to, the results of research and development efforts, the effect of regulation by the United States Food and Drug Administration and other agencies, the impact of competitive products, product development commercialisation and technological difficulties, and other risks detailed in the Company’s periodic reports filed with the Securities and Exchange Commission.

ST. PAUL, MN–(Marketwire – July 14, 2010) –  HealthEast Care System is pleased to announce that Ann Schrader, Chief Operating Officer, has received two awards in the past two months for her significant contributions to Minnesota healthcare.

Schrader was named a 2010 Health Care Hero in Administrative Excellence by Twin Cities Business magazine and Medica. She was deemed one of eight of Minnesota’s outstanding contributors to the quality of health care in the state, selected from dozens of nominees for her time, focus, compassion, commitment, efforts, and imagination in delivering significant improvements in health care. Her drive to create a patient-centered experience, gold standard employee engagement, exceptional clinical outcomes, and dependable financial performance led to this honor.

Schrader, whose roots are as an RN caring for patients at the bedside, has spent the last 30 years as a senior leader at HealthEast. In 1986, she was instrumental in the merger of several St. Paul hospitals to create HealthEast Care System, the first successful unification of hospitals representing three Christian faiths in America. Schrader became HealthEast’s Chief Operating Officer in 1994. 

As operations leader, she was part of a team that brought about many firsts for HealthEast including:

• St. Joseph’s, St. John’s and Woodwinds were the first hospitals in Minnesota to perform surgeries live on the Internet.
• Bethesda Hospital became one of only two long-term acute care hospitals in the state.
• HealthEast launched an online prenatal education program, the first of its kind in the United States.
• HealthEast implemented a care navigation strategy that was the first of its kind in the Twin Cities.
• Woodwinds Health Campus officially opened in Woodbury; it was the first hospital of its kind to offer a unique environment blending integrative medicine, technology, customer service, and a healing nature for patients and their families.

Tim Hanson, HealthEast Care System Chief Executive Officer, credits Schrader for being an essential driver of best practices at all levels of the organization. “Her sense of integrity, honesty, innovation, and accountability have been at the foundation of HealthEast’s success,” said Hanson. “Her vision and strategic planning acumen have helped us respond effectively to a constantly changing industry.”

Schrader has also been selected by the Women’s Healthcare Leadership Trust to receive its Jean Harris Award. The Trust is a 30-year-old organization whose primary purpose is to support, educate, and promote women leaders in healthcare. Established in 2001, this award reflects the vision, integrity, and public leadership of Jean Harris, a physician and former mayor of Eden Prairie, who was known for making a difference in the health care of our communities.

Over the years, Schrader has given her time and talent as a board member to many organizations reflecting a broad spectrum of interests (ranging from business leadership to social services). In addition, she has served as a coach and mentor for many aspiring leaders at HealthEast as well as MHA and MBA students from the University of Minnesota, University of St. Thomas, St. Catherine University, and Mentiumm 100.

These awards celebrate Schrader’s innovative service and program contributions to HealthEast as well as her lifetime commitment to helping young healthcare professionals grow and develop their talents and competencies.

HealthEast Care System is a community-focused, non-profit health care organization that provides innovative technology, compassionate care and a full spectrum of family health services. HealthEast includes Bethesda Hospital, St. John’s Hospital, St. Joseph’s Hospital, and Woodwinds Health Campus as well as outpatient services, clinics, home care, and medical transportation services. Practicing financial responsibility, HealthEast is the largest, locally-owned health care organization in the Twin Cities’ East Metro with 7,300 employees, 1,200 volunteers and 1,400 physicians on staff.

BENSALEM, PA–(Marketwire – July 13, 2010) – Healthcare Services Group, Inc. (NASDAQ: HCSG)
reported that revenues for the three months ended June 30, 2010 increased
13% to $192,954,000 compared to $170,896,000 for the same 2009 period. Net
income for the three months ended June 30, 2010 increased 12% to $8,721,000
or $.20 per basic and per diluted common share, compared to the 2009 second
quarter net income of $7,815,000 or $.18 per basic and per diluted common
share.

Revenues for the six months ended June 30, 2010 increased 14% to
$376,755,000 compared to $331,305,000 for the same 2009 period. Net income
for the six months ended June 30, 2010 increased 4% to $16,149,000 or $.37
per basic and $.36 per diluted common share compared to the 2009 six month
period net income of $15,551,000 or $.36 per basic and $.35 per diluted
common share.

The Board of Directors has declared a second quarter 2010 regular quarterly
cash dividend of $.23 per common share, payable on August 6, 2010 to
shareholders of record at the close of business July 23, 2010. This
represents a 5% increase over the dividend declared for the 2010 first
quarter and a 21% increase over the 2009 same period payment. It is the
29th consecutive regular quarterly cash dividend payment, as well as the
28th consecutive increase since our initiation of regular quarterly cash
dividend payments in 2003.

The Company will host a conference call on July 14, 2010 at 8:30 AM Eastern
Time to discuss its results for the three and six month periods ended June
30, 2010. The call in numbers are 800-401-3551 and 913-312-0688 (passcode #
2084962).

Cautionary Statement Regarding Forward-Looking Statements

This release and any schedules incorporated by reference into this report
contain forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934 (the “Exchange Act”), as amended, are not historical
facts but rather based on current expectations, estimates and projections
about our business and industry, our beliefs and assumptions. Words such as
“believes,” “anticipates,” “plans,” “expects,” “will,” “goal,” and similar
expressions are intended to identify forward-looking statements. The
inclusion of forward-looking statements should not be regarded as a
representation by us that any of our plans will be achieved. We undertake
no obligation to publicly update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise. Such
forward-looking information is also subject to various risks and
uncertainties. Such risks and uncertainties include, but are not limited
to, risks arising from our providing services exclusively to the health
care industry, primarily providers of long-term care; credit and collection
risks associated with this industry; one client accounting for
approximately 11% of revenues in the six month period ended June 30, 2010;
risks associated with our acquisition of Contract Environmental Services,
Inc. including integration risks and costs, or such business not achieving
expected financial results or synergies or failure to otherwise perform as
expected; our claims experience related to workers’ compensation and
general liability insurance; the effects of changes in, or interpretations
of laws and regulations governing the industry, our workforce and services
provided, including state and local regulations pertaining to the
taxability of our services; and the risk factors described in our Form 10-K
filed with the Securities and Exchange Commission for the year ended
December 31, 2009 in Part I thereof under “Government Regulation of
Clients,” “Competition” and “Service Agreements/Collections,” and under
Item IA “Risk Factors.” Many of our clients’ revenues are highly contingent
on Medicare and Medicaid reimbursement funding rates, which Congress has
affected through the enactment of a number of major laws during the past
decade, most recently the March 2010 enactment of the Patient Protection
and Affordable Care Act and the Health Care and Education Reconciliation
Act of 2010. Currently, the U.S. Congress is considering changes or
revising legislation to reform health care in the United States which,
among other initiatives, may impose cost containment measures impacting our
clients. These laws and proposed laws have significantly altered, or
threatened to alter, overall government reimbursement funding rates and
mechanisms. The overall effect of these laws and trends in the long-term
care industry have affected and could adversely affect the liquidity of our
clients, resulting in their inability to make payments to us on agreed upon
payment terms. These factors, in addition to delays in payments from
clients, have resulted in, and could continue to result in, significant
additional bad debts in the near future. Additionally, our operating
results would be adversely affected if unexpected increases in the costs
of labor and labor related costs, materials, supplies and equipment used in
performing services could not be passed on to our clients.

In addition, we believe that to improve our financial performance we must
continue to obtain service agreements with new clients, provide new
services to existing clients, achieve modest price increases on current
service agreements with existing clients and maintain internal cost
reduction strategies at our various operational levels. Furthermore, we
believe that our ability to sustain the internal development of managerial
personnel is an important factor impacting future operating results and
successfully executing projected growth strategies.

Healthcare Services Group, Inc. is the largest national provider of
professional housekeeping, laundry and dietary services to long-term care
and related facilities.

                     HEALTHCARE SERVICES GROUP, INC.
               CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                               (Unaudited)

                                               For the Three Months Ended
                                                        June 30,
                                                  2010           2009
                                              -------------  --------------
Revenues                                      $ 192,954,000  $  170,896,000
Operating costs and expenses:
   Cost of services provided                    165,240,000     145,830,000
   Selling, general and administrative           13,150,000      13,516,000
                                              -------------  --------------
Income from operations                           14,564,000      11,550,000
Other income (loss):
    Investment and interest income (loss)          (383,000)      1,157,000
                                              -------------  --------------
Income before income taxes                       14,181,000      12,707,000
Income taxes                                      5,460,000       4,892,000
                                              -------------  --------------
Net income                                    $   8,721,000  $    7,815,000
                                              =============  ==============

Basic earnings per common share               $         .20  $          .18
                                              =============  ==============

Diluted earnings per common share             $         .20  $          .18
                                              =============  ==============

Cash dividends per common share               $         .22  $          .18
                                              =============  ==============
Basic weighted average number of common shares
 outstanding                                     43,965,000      43,537,000
                                              =============  ==============

Diluted weighted average number of common
 shares outstanding                              44,652,000      44,262,000
                                              =============  ==============




                     HEALTHCARE SERVICES GROUP, INC.
               CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                               (Unaudited)

                                                 For the Six Months Ended
                                                         June 30,
                                                    2010          2009
                                                ------------- -------------
Revenues                                        $ 376,755,000 $ 331,305,000
Operating costs and expenses:
   Cost of services provided                      323,812,000   283,722,000
   Selling, general and administrative             27,051,000    24,392,000
                                                ------------- -------------
Income from operations                             25,892,000    23,191,000
Other income:
    Investment and interest income                    366,000     2,094,000
                                                ------------- -------------
Income before income taxes                         26,258,000    25,285,000
Income taxes                                       10,109,000     9,734,000
                                                ------------- -------------
Net income                                      $  16,149,000 $  15,551,000
                                                ============= =============

Basic earnings per common share                 $         .37 $         .36
                                                ============= =============

Diluted earnings per common share               $         .36 $         .35
                                                ============= =============

Cash dividends per common share                 $         .43 $         .35
                                                ============= =============
Basic weighted average number of common shares
 outstanding                                       43,932,000    43,497,000
                                                ============= =============

Diluted weighted average number of common shares
 outstanding                                       44,655,000    44,168,000
                                                ============= =============




                      HEALTHCARE SERVICES GROUP, INC.

                  CONDENSED CONSOLIDATED BALANCE SHEETS
                                (Unaudited)

                                                               December 31,
                                                June 30, 2010      2009
                                                ------------- -------------
Cash and cash equivalents                       $  34,968,000 $  31,301,000
Marketable securities, net                         44,099,000    52,648,000
Accounts receivable, net                          107,253,000   104,356,000
Other current assets                               23,715,000    23,865,000
                                                ------------- -------------
  Total current assets                            210,035,000   212,170,000

Property and equipment, net                         4,931,000     4,391,000
Notes receivable- long term, net                    6,165,000     4,623,000
Goodwill , net                                     16,955,000    17,087,000
Other Intangible Assets, net                        8,198,000     8,862,000
Deferred compensation funding                      11,238,000    10,783,000
Other assets                                        9,032,000     7,976,000
                                                ------------- -------------

Total Assets                                    $ 266,554,000 $ 265,892,000
                                                ============= =============


Accrued insurance claims- current               $   5,305,000 $   4,844,000
Other current liabilities                          27,237,000    29,873,000
                                                ------------- -------------
  Total current liabilities                        32,542,000    34,717,000

Accrued insurance claims- long term                12,377,000    11,302,000
Deferred compensation liability                    11,479,000    11,099,000
Stockholders' equity                              210,156,000   208,774,000
                                                ------------- -------------

Total Liabilities and Stockholders' Equity      $ 266,554,000 $ 265,892,000
                                                ============= =============

ORLANDO, FL–(Marketwire – July 13, 2010) –  WellCity, Inc. (http://www.wellcity.com), a wellness-related social network and subsidiary of WellTek, Inc. (OTCBB: WTKN), today unveiled WellCity Market^™, its network marketing platform, calling all consumers and network marketers to be one of the first to join this ground-breaking opportunity to create optimum health and long-term wealth by getting social inside WellCity.

“Until now, social network users have had no way to leverage their personal network as a direct income opportunity. Today, we’ve changed that,” said David George, CEO of WellCity. “We are the first social network to offer actual money to its users. With the integration of WellCity Market, our WellCity ‘residents’ have an unprecedented opportunity to help others achieve optimal health, while they earn income from the purchases made by their network of family and friends or ‘neighbors.’ It’s a simple idea: users get paid every time their ‘neighbors’ make a purchase inside WellCity Market.”

WellCity Market offers a breadth of natural products to help others live a more enriched life physically, spiritually and financially. The technology of online social networking provides the single most effective medium today for creating long-term wealth and for teaching people about new products and services that help people feel better, lose weight, prevent disease and become younger and stronger even as people grow older.

According to world-renowned economist Paul Zane Pilzer, the emerging Wellness Industry has quickly become the hottest trend in the world today and it is predicted to reach $1 trillion by 2012. Furthermore, according to Direct Selling News, well over $70 billion dollars in revenue was generated in 2009 by the top 100 network marketing companies. “The convergence of the Wellness Industry with Network Marketing and Social Networking provides an extraordinary opportunity for our residents in WellCity, as well our shareholders; we are creating the perfect storm of opportunity,” said Randy Lubinsky, Chairman and CEO of WellTek. “It’s comparable to merging Amway with Facebook.”

About WellCity Incorporated
WellCity is a social utility where health- and wellness-minded ‘residents’ can closely commune with one another; receive support, information and encouragement from their ‘neighbors’ and from a league of leading professional experts; shop for health and wellness-oriented product and services; compete in WellCity’s proprietary 90-Day Wellness Challenge; and even enjoy income opportunities by leveraging their personal network. For more information on the Company, please visit www.WellCity.com.

About WellTek Incorporated
WellTek is a global health, fitness and wellness company that provides proven solutions to help address some of the world’s most pressing and costly health and wellness challenges. The Company owns and operates WellCity, Inc., a premiere wellness-related social utility that helps ‘residents’ live happier, healthier, longer lives. The Company’s subsidiary, MedX Limited, manufactures, markets and distributes the most advanced medical exercise equipment to the medical and fitness markets. Through its wholly owned subsidiary Pure HealthyBack, Inc., WellTek is redefining healthcare delivery by providing health plans, self-insured employer groups, and consumers with a viable non-surgical, lower cost treatment for patients who are seeking lasting relief from chronic neck and back pain. For more information on the Company, please visit www.WellTekinc.com. 

Certain statements contained in this press release, which are not based on historical facts, are forward-looking statements as the term is defined in the Private Securities Litigation Reform Act of 1995, and are subject to substantial uncertainties and risks in part detailed in the respective Company’s Securities and Exchange Commission filings, that may cause actual results to materially differ from projections. Although the Company believes that its expectations are reasonable assumptions within the bounds of its knowledge of its businesses, expectations, representations and operations, there can be no assurance that actual results will not differ materially from their expectations. Important factors currently known to management that could cause actual results to differ materially from those in forward-looking statements include the Company’s ability to execute properly its business model, to raise additional capital to implement its continuing business model, the ability to attract and retain personnel — including highly qualified executives, management and operational personnel, ability to negotiate favorable future debt facilities and capital raises, and the inherent risk associated with a diversified business to achieve and maintain positive cash flow and net profitability. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this press release will, in fact, occur. 

NEW YORK, NY–(Marketwire – July 13, 2010) – Maimonides Medical Center Urologist Dr. Ridwan Shabsigh, director of the Division of Urology, created his “Ask The Doctor” medical advice talk show to help bridge the gap of men’s healthcare information in a simple-to-understand format. His online health talk show, “The Dr. Ridwan Show” delivers accurate and usable health information on common men’s health questions.

Along with an elite panel of experts, Drs. Harry Fisch, Michael Perelman and Richard Sadovsky, the group provides reliable health information to common men’s health questions. Ridwan and his medical panelists provide unique insights and advice that support the show’s tagline, “Health information you can use.” The panelists discuss a hot topic per episode in men’s health such as heart disease, prostate cancer, testosterone deficiency and erectile dysfunction.

Each episode of Dr. Ridwan’s unique online doctor consultation show concludes with helpful action tools that incite viewers to take positive actions for their health. The most helpful action tool is a men’s health calculator. This health risk calculator helps to raise awareness and motivate men to access health care services and pursue healthier lifestyles.

This men’s health calculator is not an absolute measure of risk or a substitute for professional health advice, but it helps men to assess their risk of having hypertension (high blood pressure), hyperlipidemia (high cholesterol), diabetes and/or coronary artery disease. The viewer can answer basic questions on health status, erectile dysfunction, relationships, and waist size to help determine health risk.

Other helpful tips provided on Dr. Ridwan’s doctor advice show:

• Avoid abdominal obesity to prevent heart and vascular disease risk
• Men’s health preventive ideas
• Get annual checkup and prostate screenings
• Ask for urologist referral if abnormal urinary symptoms exist
• Men should work with partners to improve health
• Review health risks and reduce these factors
• Watch for sexual problems
• Be aware of testosterone deficiency symptoms

By providing answers to medical questions online, Dr. Ridwan hopes to reduce the need for unnecessary procedures and tests. “In these times of healthcare reform, by educating my viewers, I hope to make them be more proactive in monitoring their health,” said Ridwan. “This way they won’t have to make unnecessary trips to the emergency room for something that can be taken care of in advance or prevented.”

Click here to see all recent news from this company

IRVING, TX–(Marketwire – July 13, 2010) –  Redlands Community Hospital, a 205-bed facility located in Southern California, has joined VHA Inc., the national health care network and business cooperative that serves 1,400 not-for-profit hospitals across the nation. Redlands wants to enhance its ability to network with other providers in the region to develop solutions to challenges they all face, such as how to enhance clinical quality in the face of dwindling resources. 

“Most hospitals and health systems are drawn to VHA because of its supply chain management services, but that wasn’t a primary motivator for us,” said Jim Holmes, president and chief executive officer at RCH, which purchases about $25 million in supplies annually. “The health care marketplace is an increasingly challenging environment, and we determined that it would be best for RCH to be part of a larger network of hospitals, without giving up our local control. VHA provides that opportunity.”

The CEO of another VHA member hospital in California, Jim West at Presbyterian Intercommunity Hospital in Whittier, actually sold Holmes on VHA. “I explained that being a member of VHA connects our organization to thought leaders and solutions that we need to improve performance. Being a member of VHA creates leverage and gives us clout we don’t have on our own. I think that discussion made the decision to join VHA easier for Redlands,” said West.

In addition to joining VHA’s national network, RCH is also joining VHA’s regional network, VHA West Coast, which links more than 90 hospitals in Arizona, California, Hawaii, Nevada and one hospital in both Oregon and Washington. Through VHA, these organizations leverage their knowledge, purchasing clout and other resources to help each other improve.

“VHA creates connections and energy that enable hospitals to accelerate their performance,” said Rick Barnett, senior vice president of VHA’s West Coast office, located in Pleasanton, Calif. “We’re excited about having RCH in the VHA family. We’ve pursued the organization for two years, and we believe RCH will benefit through its membership, and it will deliver benefits to other members as the RCH team interacts with VHA peers.” 

About VHA

Based in Irving, Texas, VHA is a national network of not-for-profit health care organizations that work together to drive maximum savings in the supply chain arena, set new levels of clinical performance and identify and implement best practices to improve operational efficiency and clinical outcomes. Formed in 1977, through its 16 regional offices, VHA serves more than 1,400 hospitals and more than 28,000 non-acute care providers nationwide. VHA was ranked by Modern Healthcare as the 7th best place to work in health care in 2009.

SAN DIEGO, CA–(Marketwire – July 13, 2010) –  International Stem Cell Institute (ISCI, www.iStemCelli.com) announced today the launch of highly effective Stem Cell Therapy treatments aimed at providing a better quality of life for those suffering with Cerebral Palsy (CP).

Details are available at www.iStemCelli.com/cerebralpalsy.html or calling 800-609-7795.

ISCI Executive Director Rita Alexander maintains, “Every parent wants their child to live a happy, healthy life as a baby, as a toddler, as a first grader. CP is a tremendously overwhelming condition — it’s really hard to understand the daily frustrations parents go through when a child is diagnosed with CP. And while the condition can’t be completely cured, our stem cell treatment is dramatically improving the quality of life for many children, much beyond their parent’s expectations. The results are truly amazing.”

Cerebral Palsy is not a disease like chicken pox or measles. It is an umbrella term for a group of related disorders stemming from different causes. The condition seriously affects muscle movement, and is caused by abnormalities in the brain. One million children in the US are afflicted with CP, and more will be diagnosed as we see an increase in the survival of premature infants and multiple births.

According to Alexander, CP is often associated with injury in the womb or during birth, and especially evident in premature infants. Alexander notes, “The earlier we can treat an infant or child with Stem Cell Therapy the greater the positive impacts on their future development.” She continues, “We’re working with very young children and infants. Stem Cell Therapy is a very gentle treatment, it’s gentle enough for a six month old baby.”

The procedure — safely and comfortably administering placental stem cells into several key parts of the body — is a leading-edge alternative CP treatment proving highly effective for infants and even older children afflicted with CP. Alexander relates, “The good thing is parents don’t have to wait for the new developments in this field, the procedure is available right now and affordable for most families.”

Stem cell therapy has been shown to relieve a wide variety of CP symptoms. Alexander claims, “We’re treating children with a variety of symptoms, like the lack of muscle coordination, those who have stiff and tight muscles or floppy muscles, children with exaggerated reflexes and children dragging one foot or walking on their toes.”

ISCI’s Stem Cell Therapy treatments are also being hailed as a potent medical tool in treating the seizures, difficulty with vision, hearing and speech, incontinence, and recurring lung infections that children can often experience with CP.

ISCI’s CP patient advocate, LeiMomi Ferrill, has personally seen impressive results with stem cell therapy in CP patients. “You’re heart really goes out to these parents and children. When a parent tells us their child can now roll over, or talk or balance a bit, they’re walking through a door where they feel there is hope for the very first time. We have one child, William, who was practically comatose and unable to communicate. He’s now telling his Mother he loves her, knows and calls his brothers by name, and is talking with his family about what he likes to eat.”

Alternative treatments currently being explored for CP include electrical stimulation — pulsing electricity into the motor nerves — and hyperbaric oxygen therapy in which high concentrations of oxygen are forced into brain tissues under pressure. Researchers at the University of Georgia are conducting the first ever FDA approved stem cell clinical trials for brain injuries. Dr. James Carroll, chief of pediatric neurology at the MCG School of Medicine, claims, “Stem cell therapies using cord blood have been used successfully for more than 20 years, but here we have a study which is breaking new ground in advancing therapies for brain injury.”

ISCI strongly supports scientific research on CP, especially the work of the Cerebral Palsy International Research Foundation (CPIRF), the leading nongovernmental organization funding advanced research in CP.

Patients and families with Cerebral Palsy are encouraged to learn about treatments by calling the International Stem Cell Institute at 800-609-7795 or online at www.istemcelli.com/cerebralpalsy.html.

About ISCI (www.iStemCelli.com)
ISCI is an innovator in stem cell therapy and regenerative medicine dedicated to providing a pathway to treatments which may improve health and quality of life for thousands of people with degenerative diseases around the world. Over 3,000 patients have safely undergone stem cell treatments. The company accepts patients globally, and is dedicated to the highest medical and ethical standards.

Disclaimer: Stem Cell Therapies offered for consideration by International Stem Cell Institute are not currently approved by the FDA and the treatments and procedures mentioned take place outside the USA. Stem Cell Treatments are not a cure for any condition, disease or injury, nor a substitute for proper medical diagnosis and care. The information contained in this press release and ISCI’s written materials should not be considered medical advice. It is intended to be used for educational and information purposes only.

MUNDELEIN, IL–(Marketwire – July 13, 2010) – Medline Industries, Inc., the nation’s largest privately held manufacturer and distributor of healthcare supplies, today announced the winners of its inaugural 2009 Preferred Vendor Recognition Awards. Selected by a panel of executives from Medline’s Preferred HealthCare Division, the Preferred Vendor Awards were given to four Medline partners who not only demonstrated outstanding performance in sales and operations but also have collaborated as a true partner in Medline’s initiatives and in achieving mutual goals.

The following companies were honored at Medline’s 2010 National Meeting and Sales Conference in Montgomery, TX:

• Rookie Vendor of the Year: SunTech Medical (Morrisville, NC) was recognized for their support and sales growth of the SunTech 247 vital signs device since Medline launched the product in May 2009. 
• Vendor of the Year: Abbott Diabetes Care (Alameda, CA) was honored as the Vendor of the year who demonstrated a strong commitment to sales and marketing, as well as operational and supply chain excellence.
• Sales Merit Award: Abbott Nutritional (Columbus, OH), and Caltech Industries (Midland, MI) were both recognized for showing outstanding sales growth over the prior year while maintaining key economic initiatives.

“Our partnership with vendors is an essential element of our success with our customers,” said Maroun Abouzeid, president of Preferred HealthCare. “We thank all our partners for their contributions and congratulate our award-winning partners for their ongoing leadership.”

About Medline Industries, Inc.
Medline, the nation’s largest privately held manufacturer and distributor of healthcare products, manufactures and distributes more than 100,000 products to hospitals, extended-care facilities, surgery centers, home care dealers and agencies. Headquartered in Mundelein, Ill, Medline has more than 800 dedicated sales representatives nationwide to support its broad product line and cost management services.

Over the past five years, Medline has been the fastest-growing distributor of medical and surgical supplies in the U.S., serving as the primary distributor to over 450 major hospitals and healthcare systems. As a leading distributor, Medline offers a comprehensive array of consulting and management services encompassing the supply chain and logistics, utilization and standardization, business tools and enhanced reporting capabilities and on-staff clinicians.

Medline has a growing network of 34 distribution centers around the country, as well as an expanding, dedicated transportation fleet with over 180 vehicles in a variety of sizes to fit customers’ specific delivery needs. The fleet is equipped with the latest navigation devices for enhanced order tracking and communication. 

NEW YORK, NY–(Marketwire – July 13, 2010) –  The Patient Channel, a 24/7 in-hospital television network from Interactivation Health Networks, has conducted a study for one if its pharmaceutical advertisers that demonstrates above average ROI — a 5:1 ROI after six months and 8:1 ROI after a 12 month targeted advertising campaign — further evidence of the immense value of Digital Out-of-Home advertising, particularly as it relates to hospitals as a “fourth screen” location. 

“The reason why advertising is so effective at hospital bedside, and why the Patient Channel and Newborn Channel work is simple — we provide marketers with a unique and differentiated platform that offers compelling and essential health content delivered at the precise moment it is needed most,” said Suzanne Fleming, SVP of Sales at Interactivation Health Networks. “Our channels provide the ideal branding environment where consumers are highly attentive, highly motivated and ready to act. Connecting brands with our hyper-focused audience is an opportunity that is hard to replicate with traditional television advertising.”

Interactivation Health Networks engaged IMS Consulting to perform a quantitative ROI study based upon dispensed prescribing tied to participating physicians exposed to a specified pharmaceutical company’s program. The study found that when comparing post-exposure prescribing to a similar control group of physicians, identified by IMS, the pharmaceutical company saw a +2.1% incremental increase in prescribing, representing a positive return on the pharmaceutical company’s investment with Interactivation Health Networks.

Results from the IMS study corroborate findings from studies conducted by Nielsen* and Razorfish** that project the continued rise of Out-Of-Home advertising due to the unchallenged ability to pinpoint a targeted, and often captive, audience with relevant messaging. For brands within the health and wellness field, the Interactivation Health Networks are a documented means of successfully activating these consumers.

Advertisers who use The Patient and Newborn Channels will have the added opportunity of further engaging with their target audience via Interactivation’s propriety interactive technology. This would allow viewers of ads to directly and immediately interact with the brand with their mobile device to receive more information or coupons on the advertised product. For example, consumers can locate a nearby retailer by texting their zip code to the Interactivation-owned short code promoted in their on-air commercial.

About Interactivation Health Networks
The Patient Channel and The Newborn Channel are the most comprehensive in-hospital TV networks. Delivered directly to patient rooms and waiting areas, the Channels provide viewers with original, award-winning health programs and advertisers with the unique ability to integrate brand messaging with content that is compelling and endorsed by healthcare professionals. The Newborn Channel broadcasts baby care and postpartum programming for new parents, reaching 60% of new moms. The Patient Channel features both condition-specific and preventative health programming to empower and inform patients. The channels are currently available in over 2,700 hospitals nationwide.

IMS Health Consulting conducted the study with one of the Patient Channel’s long-standing advertisers.

*Nielsen Inaugural Fourth Screen Report – April 12, 2010
**Razorfish Outlook Report 2010

NEW YORK, NY–(Marketwire – July 13, 2010) –  Healthnostics, Inc. (PINKSHEETS: HNSS), a medical and biotechnology analytics company, has completed its acquisition of Worldwide Wipes Co., “a U.S. manufacturer and distributor of wipes for medical, veterinary, disinfecting, and a variety of other uses, and the company’s market ranges from cartons for individuals to truckloads for corporations. The Company places a priority on price, quality, and convenience, providing prompt, free shipping.”

Terms of the acquisition include net profit benchmarks of $300,000 to $600,000 in the first year and $600,000 to $900,000 in the second year.

“We are pleased to announce the completion of the most important event in our Company’s history. The Worldwide Wipes price points are exceptionally competitive, and its customer base is nationwide. Following several years of base-building, this acquisition represents such a quantum leap for Healthnostics that we are contemplating a name and stock symbol change that reflects the diversified nature and direction of the Company,” said President Alan Grofe.

About Healthnostics

Healthnostics, Inc. is a medical and biotechnology analytics company that provides comprehensive patient clinical monitoring and risk management systems to acute care hospitals and utilizes its Internet portals to deliver medical and biotechnology resource information to industry professionals as well as to the general public. Healthnostics’ major products include: Worldwide Wipes Co., a manufacturer and distributor of medical and other wipes, MedGuardian, a patient care monitoring and risk management system for hospitals that is fully Web-based; and through the MedBioWeb subsidiary, MedBioWorld™, one of the largest professional medical and biotechnology directory resource and reference portal sites on the Internet, and FamilyMedicalNet, a companion consumer healthcare information portal.

For further information please visit Healthnostics www.healthnostics.com, and Worldwide Wipes Co. www.wipesco.com, MedBioWorld www.medbioworld.com, and FamilyMedicalNet www.familymedicalnet.com.

And visit us on Facebook at www.facebook.com/Healthnostics.

This press release may contain certain statements that are not descriptions of historical information, but are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Exchange Act of 1934. These forward-looking statements refer to matters that involve risks and uncertainties. Such statements reflect management’s current views and are based on certain assumptions. Actual results could differ materially from the assumptions currently anticipated.